As of 2026-09-23, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (18.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 10.64 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -276.7%.
The range of the Relative Valuation is (17.55) - (19.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.1x - 31.7x | 29.7x |
| Forward P/E multiples | 26.6x - 29.6x | 28.3x |
| Fair Price | (17.55) - (19.17) | (18.80) |
| Upside | -264.9% - -280.1% | -276.7% |
| Date | P/E |
| 2026-09-22 | -16.41 |
| 2026-09-21 | -15.72 |
| 2026-09-18 | -15.81 |
| 2026-09-17 | -15.45 |
| 2026-09-16 | -15.22 |
| 2026-09-15 | -14.44 |
| 2026-09-14 | -14.28 |
| 2026-09-11 | -13.26 |
| 2026-09-10 | -12.55 |
| 2026-09-09 | -13.00 |
| 2026-09-08 | -13.42 |
| 2026-09-04 | -13.56 |
| 2026-09-03 | -13.42 |
| 2026-09-02 | -13.29 |
| 2026-09-01 | -12.77 |
| 2026-08-31 | -12.60 |
| 2026-08-28 | -12.35 |
| 2026-08-27 | -12.74 |
| 2026-08-26 | -12.46 |
| 2026-08-25 | -13.02 |
| 2026-08-24 | -12.43 |
| 2026-08-21 | -12.79 |
| 2026-08-20 | -13.86 |
| 2026-08-19 | -12.32 |
| 2026-08-18 | -10.84 |
| 2026-08-17 | -10.95 |
| 2026-08-14 | -10.76 |
| 2026-08-13 | -10.06 |
| 2026-08-12 | -10.39 |
| 2026-08-11 | -10.01 |
| 2026-08-10 | -9.87 |
| 2026-08-07 | -9.78 |
| 2026-08-06 | -9.58 |
| 2026-08-05 | -6.69 |
| 2026-08-04 | -6.72 |
| 2026-08-03 | -6.65 |
| 2026-07-31 | -6.28 |
| 2026-07-30 | -7.23 |
| 2026-07-29 | -7.03 |
| 2026-07-28 | -7.25 |
| 2026-07-27 | -7.56 |
| 2026-07-24 | -7.70 |
| 2026-07-23 | -7.91 |
| 2026-07-22 | -7.97 |
| 2026-07-21 | -8.45 |
| 2026-07-20 | -7.74 |
| 2026-07-17 | -7.71 |
| 2026-07-16 | -7.19 |
| 2026-07-15 | -7.31 |
| 2026-07-14 | -6.06 |